Coco de Koning
Thymus recovery as a key to better immunity and outcome after Cancer Therapy
Contact details
For children with high-risk blood cancers, a donor stem cell transplantation (SCT) is often the last chance for cure. Despite modern care, fewer than half of these children survive long term. The cancer may return, or serious complications such as infections or graft-versus-host disease can occur, where donor immune cells attack the patient’s body. A fast and effective recovery of the immune system is crucial for success, yet we still do not fully understand what drives this process.
As a senior postdoctoral researcher in Tumor Immunology in the Nierkens group, I study immune recovery after SCT in children. My research focuses on the thymus, a small organ located above the heart that produces new immune cells. Traditionally, immune recovery after transplantation was thought to rely mainly on the expansion of donor immune cells. However, our work shows that the thymus may play a much larger and previously underappreciated role. In addition to producing immune cells, the thymus also functions as an endocrine organ, releasing hormones that can support and regulate immune recovery.
My team investigates how these thymic hormones promote early immune reconstitution after SCT and how this contributes to fewer complications and better survival. We are among the few groups worldwide studying this “forgotten” function of the thymus in children with cancer. By combining basic and translational immunology at the Wilhelmina Children’s Hospital, we aim to translate fundamental insights into clinical benefit.
Our findings are also relevant for immune recovery after chemotherapy, radiotherapy, and immunotherapies such as CAR-T cells. Ultimately, I hope this research will lead to thymus-based treatments that help children rebuild stronger immune systems and improve both short- and long-term outcomes after cancer treatment.
- Publications